Puma Biotechnology



Ebitda Alterar Data
Agios Pharmaceuticals USD -105351000 18.32M 2025-03
Alnylam Pharmaceuticals USD 32.48M 123.47M 2025-03
Amgen USD 3.75B 42M 2025-03
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Exelixis USD 194.2M 23.1M 2025-04
Gilead Sciences USD 3.21B 651M 2024-12
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Incyte USD 222.66M 97.54M 2025-03
MacroGenics USD -50784000 106.81M 2024-12
Moderna USD -924000000 69M 2025-03
Novartis USD 5.19B 319M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
PTC Therapeutics USD 1.07M 47.25M 2024-12
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD -290408000 472.62M 2025-03
Takeda JPY 128.14B 126.45B 2025-03
TG Therapeutics USD 29.96M 12.91M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Puma Biotechnology - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.